Cargando…

Standardization of a Method to Evaluate the Antioxidant Capacity of High-Density Lipoproteins

Background: A method to evaluate the antioxidant capacity of high-density lipoprotein (HDL) was developed and standardized. Methods: This method measure conjugated diene (CD) formation and electrophoretic mobility of low-density lipoprotein (LDL) in agarose gels in the presence and absence of HDL. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Juan-Franco, Elena, Pérez, Antonio, Ribas, Vicent, Sánchez-Hernández, Juan Antonio, Blanco-Vaca, Francisco, Ordóñez-Llanos, Jordi, Sánchez-Quesada, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Master Publishing Group 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614798/ https://www.ncbi.nlm.nih.gov/pubmed/23675165

Ejemplares similares

Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes
por: Sánchez-Quesada, Jose Luis, et al.
Publicado: (2013)

Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
por: Colom, Cristina, et al.
Publicado: (2018)

The Induction of Cytokine Release in Monocytes by Electronegative Low-Density Lipoprotein (LDL) Is Related to Its Higher Ceramide Content than Native LDL
por: Estruch, Montserrat, et al.
Publicado: (2013)

Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype
por: Vinagre, Irene, et al.
Publicado: (2014)

Endothelial lipase increases antioxidative capacity of high-density lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2019)

Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation
por: Estruch, Montserrat, et al.
Publicado: (2013)

Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected Patients
por: Saumoy, Maria, et al.
Publicado: (2021)

Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins
por: Tsunoda, Fumiyoshi, et al.
Publicado: (2016)

Moderate beer consumption does not change early or mature atherosclerosis in mice
por: Escolà-Gil, Joan Carles, et al.
Publicado: (2004)

Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men
por: Nour Eldin, Essam Eldin Mohamed, et al.
Publicado: (2014)

IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein
por: de la Paz Sánchez-Martínez, María, et al.
Publicado: (2017)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm
por: Martínez-López, Diego, et al.
Publicado: (2019)

The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux—But Not Gut Microbial-Derived Metabolites—Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction
por: Canyelles, Marina, et al.
Publicado: (2021)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

Endothelial lipase increases eNOS activating capacity of high-density lipoprotein
por: Radulović, Snježana, et al.
Publicado: (2020)

Low-Density Lipoprotein (LDL)-Antioxidant Biflavonoids from Garcinia madruno
por: Osorio, Edison, et al.
Publicado: (2013)

Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
por: Fernández-de-Retana, Sofía, et al.
Publicado: (2017)

Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein
por: Sato, Megumi, et al.
Publicado: (2016)

Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2018)

Larrea divaricata: anti-inflammatory and antioxidant effects of on macrophages and low density lipoproteins
por: Peralta, Ignacio, et al.
Publicado: (2022)

Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases
por: Benitez, Sonia, et al.
Publicado: (2023)

Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins
por: Reis, Ana, et al.
Publicado: (2022)

The Alcohol–High-Density Lipoprotein Athero-Protective Axis
por: Rosales, Corina, et al.
Publicado: (2020)

Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease
por: Gómez-Sámano, Miguel Ángel, et al.
Publicado: (2021)

Oxidized Low Density Lipoprotein and Inflammation in Gout Patients
por: Jiang, Xingliang, et al.
Publicado: (2013)

Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity
por: Koekemoer, Andrea L., et al.
Publicado: (2017)

Diminished Antioxidant Activity of High‐Density Lipoprotein–Associated Proteins in Chronic Kidney Disease
por: Kennedy, David J., et al.
Publicado: (2013)

Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit
por: Brites, Fernando, et al.
Publicado: (2017)

Correction: Larrea divaricata: anti-inflammatory and antioxidant effects on macrophages and low density lipoproteins
por: Peralta, Ignacio, et al.
Publicado: (2022)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Association between total antioxidant capacity and mortality in ischemic stroke patients
por: Lorente, Leonardo, et al.
Publicado: (2016)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Triglycerides/Glucose and Triglyceride/High-Density Lipoprotein Cholesterol Indices in Normal and Preeclamptic Pregnancies: A Longitudinal Study
por: Poveda, Natalia Elvira, et al.
Publicado: (2018)

Familial Combined Hyperlipidemia (FCH) Patients with High Triglyceride Levels Present with Worse Lipoprotein Function Than FCH Patients with Isolated Hypercholesterolemia
por: Puig, Núria, et al.
Publicado: (2020)

FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells
por: Muñoz, Juan Pablo, et al.
Publicado: (2023)

Resistin Modulates Low-Density Lipoprotein Cholesterol Uptake in Human Placental Explants via PCSK9
por: Nava-Salazar, Sonia, et al.
Publicado: (2022)

Association of ANGPTL3 polymorphisms with high‐density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease
por: Aghasizadeh, Malihe, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease
por: Hisauchi, Itaru, et al.
Publicado: (2021)

Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study
por: Di Yacovo, Silvana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ce4rl6dq3luk3014pp4oq26mlu